SCOPUS 정보 검색 플랫폼

Genetics in Medicine

Volumn 16, Issue 12, 2014, Pages 869-870

Utility before business

(4) Teutsch, Steven M a Fielding, Jonathan E b,c Khoury, Muin J d,e Evans, James P f

a Los Angeles County Department of Public Health (United States)

b UNIVERSITY OF CALIFORNIA (United States)

c UNIVERSITY OF CALIFORNIA (United States)

d NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES (United States)

e NATIONAL CANCER INSTITUTE (United States)

f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLUE CROSS BLUE SHIELD; CANCER CHEMOTHERAPY; CLINICAL LABORATORY; CLINICAL MEDICINE; COST CONTROL; DISTRESS SYNDROME; DNA SEQUENCE; GENETIC SCREENING; GENOMICS; HEALTH CARE SYSTEM; HEALTH SURVEY; HUMAN; INCIDENTAL FINDING; LABORATORY TEST; MARKETING; MEDICAL GENETICS; NEWBORN SCREENING; NEXT GENERATION SEQUENCING; NOTE; PATIENT PREFERENCE; QUALITY CONTROL; NEOPLASMS; PROCEDURES;

GENETIC TESTING; GENOMICS; HUMANS; NEOPLASMS;

EID: 84920772792 PISSN: 10983600 EISSN: 15300366 Source Type: Journal
DOI: 10.1038/gim.2014.71 Document Type: Note

Times cited : (3)

References (12)

1
- 84896628886
- Prioritizing genomic applications for action by level of evidence: A horizon-scanning method
- Dotson WD, Douglas MP, Kolor K, et al. Prioritizing genomic applications for action by level of evidence: a horizon-scanning method. Clin Pharmacol Ther 2014;95:394-402
- (2014) Clin Pharmacol Ther , vol.95 , pp. 394-402
- Dotson, W.D.¹ Douglas, M.P.² Kolor, K.³

2
- 77954220352
- US System of Oversight of Genetic Testing. US Department of Health and Human Services. Accessed 11 May 2014
- US System of Oversight of Genetic Testing. A Response to the Charge of the Secretary of Health and Human Services. US Department of Health and Human Services, 2008. http://www4.od.nih.gov/oba/sacghs/reports/sacghs-oversight-report.pdf. Accessed 11 May 2014
- (2008) A Response to the Charge of the Secretary of Health and Human Services

3
- 77951482885
- Outcomes of interest in evidence-based evaluations of genetic tests
- EGAPP Working Group
- Botkin JR, Teutsch SM, Kaye CI, et al.; EGAPP Working Group. Outcomes of interest in evidence-based evaluations of genetic tests. Genet Med 2010;12:228-235
- (2010) Genet Med , vol.12 , pp. 228-235
- Botkin, J.R.¹ Teutsch, S.M.² Kaye, C.I.³

4
- 84875943185
- The arrival of genomic medicine to the clinic is only the beginning of the journey
- Evans JP, Khoury MJ. The arrival of genomic medicine to the clinic is only the beginning of the journey. Genet Med 2013;15:268-269
- (2013) Genet Med , vol.15 , pp. 268-269
- Evans, J.P.¹ Khoury, M.J.²

5
- 84867725432
- Institute of Medicine. National Academies Press: Washington DC
- Institute of Medicine. Best Care at Lower Cost: The Path to Continuously Learning Health Care in America. National Academies Press: Washington, DC, 2013
- (2013) Best Care at Lower Cost: The Path to Continuously Learning Health Care in America

6
- 84869173589
- A health dividend for America: The opportunity cost of excess healthcare expenditures in the United States
- McCullough JM, Zimmerman FJ, Fielding JE, Teutsch SM. A health dividend for America: the opportunity cost of excess healthcare expenditures in the United States. Am J Prev Med 2012;43:650-654
- (2012) Am J Prev Med , vol.43 , pp. 650-654
- McCullough, J.M.¹ Zimmerman, F.J.² Fielding, J.E.³ Teutsch, S.M.⁴

7
- 84927518802
- The business of genomic testing: A survey of early adopters
- (this issue)
- Crawford JM, Bry L, Pfeiffer J, et al. The business of genomic testing: a survey of early adopters. Genet Med 2014;16:954-961 (this issue)
- (2014) Genet Med , vol.16 , pp. 954-961
- Crawford, J.M.¹ Bry, L.² Pfeiffer, J.³

8
- 85205859250
- Blue Cross Blue Shield Association Special report: exome sequencing for clinical diagnosis of patients with suspected genetic disorders. Accessed 11 May 2014
- Blue Cross Blue Shield Association. Special report: exome sequencing for clinical diagnosis of patients with suspected genetic disorders. 2013. http://www.bcbs. com/blueresources/tec/vols/28/28-03.pdf. Accessed 11 May 2014
- (2013)

9
- 84896797913
- Clinical application of whole-genome sequencing: Proceed with care
- Feero WG. Clinical application of whole-genome sequencing: proceed with care. JAMA 2014;311:1017-1019
- (2014) JAMA , vol.311 , pp. 1017-1019
- Feero, W.G.¹

10
- 84880535720
- ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
- American College of Medical Genetics and Genomics
- Berg JS, Grody WW, Kalia SS, et al; American College of Medical Genetics and Genomics. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 2013;15:565-574
- (2013) Genet Med , vol.15 , pp. 565-574
- Berg, J.S.¹ Grody, W.W.² Kalia, S.S.³

11
- 20444374342
- ACCE: A model process for evaluating data on emerging genetic tests
- Khoury M, Little J, Burke W (eds) . Oxford University Press: New York
- Haddow JE, Palomaki GE. ACCE: A model process for evaluating data on emerging genetic tests. In: Khoury M, Little J, Burke W (eds). Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease. Oxford University Press: New York, 2003:217-233
- (2003) Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease , pp. 217-233
- Haddow, J.E.¹ Palomaki, G.E.²

12
- 84895798774
- Economic analyses of genetic tests in personalized medicine: Clinical utility first, then cost utility
- Grosse SD. Economic analyses of genetic tests in personalized medicine: clinical utility first, then cost utility. Genet Med 2014;16:225-227
- (2014) Genet Med , vol.16 , pp. 225-227
- Grosse, S.D.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.